Assessing the risk of rapid radiographic progression in Hungarian rheumatoid arthritis patients

[1] Smolen JS(2016)Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force Ann Rheum Dis 75 3-15

[2] Breedveld FC(2009)A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis Rheumatology (Oxford) 48 1114-1121

[3] Burmester GR(2011)The treatment of arthritis with synthetic and biological disease modifying drugs Hung Rheumatol 52 12-27

[4] Bykerk V(2009)Prediction of the risk of rapid radiographic progression in rheumatoid arthritis. Evaluation of the use of the matrix model by Vastesaeger et al in a real-life RA population (abstract) Hung Rheumatol 50 150-637

[5] Dougados M(2011)Effectiveness of initial treatment allocation based on expert opinion for prevention of rapid radiographic progression in daily practice of an early RA cohort Ann Rheum Dis 70 634-143

[6] Emery P(2010)Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis Autoimmun Rev 9 140-194

[7] Kvien TK(2020)Modified disease activity score at 3 months is a significant predictor for rapid radiographic progression at 12 months compared with other measures in patients with rheumatoid arthritis ACR Open Rheumatol 2 188-1377

[8] Navarro-Compan MV(2000)Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis: an early marker of progressive erosive disease Arthritis Rheum 43 1371-1485

[9] Oliver S(2006)Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis Arthritis Res Ther 8 R31-1284

[10] Schoels M(2017)Association of tumor necrosis factor-alpha (G-308A) genetic variant with matrix metalloproteinase-9 activity and joint destruction in early rheumatoid arthritis Clin Rheumatol 36 1479-1915

[1] Smolen JS(2016)Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force Ann Rheum Dis 75 3-15

[2] Breedveld FC(2009)A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis Rheumatology (Oxford) 48 1114-1121

[3] Burmester GR(2011)The treatment of arthritis with synthetic and biological disease modifying drugs Hung Rheumatol 52 12-27

[4] Bykerk V(2009)Prediction of the risk of rapid radiographic progression in rheumatoid arthritis. Evaluation of the use of the matrix model by Vastesaeger et al in a real-life RA population (abstract) Hung Rheumatol 50 150-637

[5] Dougados M(2011)Effectiveness of initial treatment allocation based on expert opinion for prevention of rapid radiographic progression in daily practice of an early RA cohort Ann Rheum Dis 70 634-143

[6] Emery P(2010)Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis Autoimmun Rev 9 140-194

[7] Kvien TK(2020)Modified disease activity score at 3 months is a significant predictor for rapid radiographic progression at 12 months compared with other measures in patients with rheumatoid arthritis ACR Open Rheumatol 2 188-1377

[8] Navarro-Compan MV(2000)Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis: an early marker of progressive erosive disease Arthritis Rheum 43 1371-1485

[9] Oliver S(2006)Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis Arthritis Res Ther 8 R31-1284

[10] Schoels M(2017)Association of tumor necrosis factor-alpha (G-308A) genetic variant with matrix metalloproteinase-9 activity and joint destruction in early rheumatoid arthritis Clin Rheumatol 36 1479-1915